# LivaNova closes $225M buyout of ImThera Medical

LivaNova closed the $225 million acquisition of ImThera Medical, which makes the Aura6000 implantable hypoglossal nerve stimulator for sleep apnea. LivaNova paid $78 million upfront, with $147 million due on milestones.

- Type: Acquisition
- Announced: 2018-01-23
- Where: San Diego, California, United States
- Value: $225.0M
- Status: completed
- Products: Aura6000 implantable hypoglossal nerve stimulator for sleep apnea
- Sectors: [Medical Devices](https://endata.com/sectors/medical-devices.md)

## Companies

- [LivaNova](https://endata.com/companies/8038.md)
- [LivaNova](https://endata.com/companies/8038.md) (acquirer)
- [MicroPort Scientific Corporation](https://endata.com/companies/20849.md) (acquirer)
- [Imthera Medical](https://endata.com/companies/28596.md) (target)
- [TandemLife](https://endata.com/companies/30056.md) (target)

## Sources

- [massdevice.com](https://www.massdevice.com/livanova-closes-225m-imthera-buyout/), 2018-01-23: "LivaNova closed the $225 million buyout of ImThera Medical and its implantable sleep apnea treatment."
- [dicardiology.com](https://www.dicardiology.com/content/livanova-enters-binding-letter-intent-sell-cardiac-rhythm-management-business), 2018-01-26: "The strong position of LivaNova’s CRM business franchise in Europe complements MicroPort’s leadership position in China and growing presence in the United States and emerging markets."
- [investor.livanova.com](https://investor.livanova.com/news-releases/news-release-details/livanova-acquire-tandemlife-0), 2018-02-14: "We are pleased to enhance our cardiac surgery product offerings with TandemLife's complete portfolio of advanced cardiopulmonary support products."
- [crtonline.org](https://www.crtonline.org/news-detail/livanova-to-acquire-tandemlife), 2018-02-15: "LivaNova PLC announced Wednesday that it has entered into an agreement to acquire TandemLife in a deal that brings together two companies that make devices for cardiac surgery."
- [medicaldevice-network.com](https://www.medicaldevice-network.com/news/mas-week-johnson-johnson-livanova-lgc-limited/), 2018-02-23: "TandemLife’s support solutions will complement LivaNova’s cardiac surgery offerings and enable the company to expand its footprint in the US and international markets."

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.